Inovio Pharmaceuticals

Inovio Pharmaceuticals

Verified

Launch date
Employees
Market cap
$426m
Net debt
$315m
Firm valuation
$112m (Public information from Sep 2022)
Plymouth Meeting Pennsylvania (HQ)

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues--27.3m3.6m6.4m<1m117m
% growth---(87 %)75 %(86 %)12800 %
EBITDA-----(235m)(115m)
% EBITDA margin-----(25800 %)(98 %)
Profit--(88.2m)(108m)(151m)(237m)(200m)
% profit margin--(323 %)(2975 %)(2371 %)(26100 %)(171 %)
EV / revenue--12.7x82.5x214.1x680.0x5.3x
EV / EBITDA------2.6x-5.4x
R&D budget51m47m57m75m---
R&D % of revenue--209 %2062 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/AN/AIPO
N/A$16.2mPost IPO Equity
N/A$63.3mPost IPO Equity
$45mGrant
N/A$500kGrant
N/A$56mPost IPO Equity
N/AKRW18.0bPost IPO Debt
Not yet verified
$5mGrant
N/A$151mPost IPO Equity
Not yet verified
Total Funding$50.5m

Recent News about Inovio Pharmaceuticals

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Inovio Pharmaceuticals

Edit
Bioject Medical Technologies
ACQUISITION by Inovio Pharmaceuticals May 2016